CAR T-Cell Therapy for Multiple Myeloma Decade Long Trends, Analysis and Forecast 2025-2033

The CAR T-cell therapy market for multiple myeloma is booming, projected to reach $168.7 million in 2025 and grow at a 28.6% CAGR through 2033. Learn about market drivers, trends, restraints, key players (Juno, Kite, Novartis, Cellectis), and regional insights.


Total Amount: $0
$6960.00
$5220.00
$3480.00

Our Clients

Choose Payment Method

Setting up secure checkout...
Secure Encrypted Transaction
Or

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Key Highlights of Report

Jun, 2025
69
Tables
Base Year: 2025.
Coverage: 18 Countries
Companies: 15+

Connect With us


avatar

Craig Francis

Head Of Sales

Email: [email protected]

+1 2315155523